CD8A and Stroke: Three days after stroke, administration of anti-CD8α mAb led to reduced brain infarct size in perioperative stroke mice (P < 0.0001) and stroke-only mice (P = 0.0262) compared with isotype IgG-treated mice (Fig. 4C, D).